Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Estrella Immunopharma, Inc. (ESLA)

NASDAQ

$0.64

$-0.03

(-4.07%)

Previous Close: ⁦$0.65⁩

Market Closed

Estrella Immunopharma, Inc. (ESLA) Live Price Chart

Last updated: ⁦2026-09-09 05:05:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Estrella Immunopharma, Inc. (ESLA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.64, with a market capitalisation of $28.11M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.59 to $3.15. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$28.11M
Open	$0.62
Day's High	$5.62
Day's Low	$0.59
Previous Close	$0.65
Volume	53.10K
Average Volume	37.40K
P/E Ratio	--
52-Week High	$3.15
52-Week Low	$0.59
Dividend Yield	--
Earnings Date	--

Estrella Immunopharma, Inc. (ESLA) Latest Closing Stock Price

Estrella Immunopharma, Inc. (ESLA) last closed at $0.65 as of 2026-09-08 20:05:00, unchanged from the previous close of $0.65.

During the latest regular trading session, ESLA traded between $0.59 and $5.62, with a volume of 53.10K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Estrella Immunopharma, Inc. (ESLA) 7-Day Stock Price Change

Over the past seven days, Estrella Immunopharma, Inc. (ESLA) moved from $0.72 to $0.64, representing a decline of 12.04% ($0.09).

The stock traded between $0.59 and $0.76 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 29.77 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ESLA 52-Week Price Position

Position in Range: 1.9%

52W Low$0.59

52W High$3.15

ESLA is currently trading at $0.64, placing it 1.9% of the way from its 52-week low of $0.59 to its 52-week high of $3.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Estrella Immunopharma, Inc. (ESLA)?

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Estrella Immunopharma, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange	NASDAQ
Company Website	https://www.estrellabio.com

How to Buy Estrella Immunopharma, Inc. (ESLA) Stock on MEXC

Eligible investors can buy real shares of Estrella Immunopharma, Inc. (ESLA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ESLA and Place Your Order

Open the RealStocks trading page and search for ESLA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Estrella Immunopharma, Inc. (ESLA) share price today?

Estrella Immunopharma, Inc. (ESLA) is currently trading at $ 0.64, down 1.75% ($0.01) from the previous close of $ 0.65. Intraday prices update in real time during regular trading hours.

2.Is ESLA stock going up or down today?

As of 2026-09-08 20:05:00, ESLA is trading at $ 0.64, down 1.75% ($0.01) from its previous close of $ 0.65. The stock has traded between $ 0.59 and $ 5.62 during today’s regular session. Past price movements do not guarantee future results.

3.What is ESLA pre-market price?

As of 2026-09-08 20:05:00, ESLA is trading at $ 0.64 in pre-market trading, down 0.97% ($0.01) from the previous close of $ 0.65. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ESLA after-hours price?

As of 2026-09-08 20:05:00, ESLA is trading at $ 0.64 in after-hours trading, down 1.75% ($0.01) from the regular-session close of $ 0.65. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is ESLA stock trading now?

ESLA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ESLA sit relative to its 52-week high and low?

Over the past 52 weeks, ESLA has traded between a low of $ 0.59 and a high of $ 3.15. At $ 0.64, the stock is positioned 1.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Estrella Immunopharma, Inc. in?

Estrella Immunopharma, Inc. (ESLA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Estrella Immunopharma, Inc.'s market capitalisation and where is it listed?

Estrella Immunopharma, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 28.11M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ESLA valued in terms of P/E ratio and EPS?

ESLA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Estrella Immunopharma, Inc. pay a dividend?

Estrella Immunopharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.